Clinical Trials Browser

Phase 1 × INDUSTRY × Cardiovascular Diseases × Clear all

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Neoplasm, Residual, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT00725634 2014-01-27

P05538

Phase 1 Completed

41 enrolled

LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Neoplasms, Plasma Cell

NCT00886353 2009-12-31

Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)

Phase 1 Completed

22 enrolled

Genitourinary

Cardiovascular Diseases, Kidney Diseases, Lung Diseases

Clinical Trials

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

P05538

Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)